NCI Resources for Cell Therapy Production
The NCI Biopharmaceutical Development Program (BDP) currently provides centralized GMP manufacturing of viral vectors and cell therapy products for extramural investigators. For more information on these production capabilites, please see these announcements:
Manufacturing support is offered through the following two mechanisms:
NCI Experimental Therapeutics (NExT) Program — Investigators seeking production of clinical grade vector and/or cell therapy products can submit proposals to the NExT Program. Applications are accepted three times per year (February, June, and October).
Cancer Therapy Evaluation Program (CTEP) — Investigators seeking clinical trial support as well as product manufacturing can submit a Letter of Intent to CTEP for acceptance into a clinical trials network such as the Experimental Therapeutics Clinical Trials Network (ETCTN).